Down-regulation of HLA Class I antigen-processing molecules in malignant melanoma: Association with disease progression

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 745-754

  Kageshita, Toshiro ^a   Hirai, Shunji ^a   Ono, Tomomichi ^a   Hicklin, Daniel J ^b   Ferrone, Soldano ^b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; HLA ANTIGEN CLASS 1; MELANOMA ANTIGEN; PROTEASOME;

ADOLESCENT; ADULT; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL;

EID: 0033034333     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65321-7     Document Type: Article

References (31)

1. Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994, 76:287-299
2. Goldberg AL, Rock KL: Proteolysis, proteasomes, and antigen presentation. Nature 1992, 357:375-379
3. Townsend A, Trowsdale J: The transporters associated with antigen presentation. Semin Cell Biol 1993, 4:53-61
4. Beck S, Kelly A, Radley E, Khurshid F, Alderton RP, Trowsdale J: DNA sequence analysis of 66kb of the human MHC class II region encoding a cluster of genes for antigen processing. J Mol Biol 1992, 228:433-441
5. Spies T, DeMars R: Restored expression of major histocompatibility Class I molecules by gene transfer of a putative peptide transporter. Nature 1991, 351:323-324
6. Powis SJ, Townsend ARM, Deverson EV, Bastin J, Butcher GW, Howard JC: Restoration of antigen presentation in the mutant cell line RMA-S by an MHC-linked transporter. Nature 1991, 354:528-531
7. Attaya M, Jameson S, Martinez CK, Hermel E, Aldrich C, Forman J, Lindahl KF, Bevan MJ, Monaco JJ: Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 1992, 355:647-649
8. Glynne R, Powis SH, Beck S, Kelly A, Kerr LA, Trowsdale J: A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 1991, 353:357-360
9. Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J: Second proteasome-related gene in the human MHC class II region. Nature 1991, 353:667-668
10. Gaczynska M, Rock KL, Spies T, Goldberg AL: Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci USA 1994, 91:9213-9217
11. Kuckelkorn U, Frentzel S, Kraft R, Kostka S, Groettrup M, Kloetzel PM: Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ. Eur J Immunol 1995, 25:2605-2611
12. Rosenberg SA, Kawakami Y, Robbins PF, Wang R: Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv Cancer Res 1996, 70:145-177
13. Ferrone S, Marincola FM: Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995, 16:487-494
14. van Duinen SG, Ruiter DJ, Broecker EB, van der Velde EA, Sorg C, Welvaart K, Ferrone S: Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res 1988, 48:1019-1025
15. Restifo NP, Marincola FM, Kawakami Y, Taubenberger J, Yannelli YR, Rosenberg SA: Loss of functional β2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst 1996, 88:100-108
16. Dellaratta DV, Hicklin DJ, Kishore R, Kageshita T, Ferrone S: Characterization of rabbit antisera elicited with human LMP2- and LMP7-specific peptides and recombinant proteins. Tissue Antigens 1997, 50:567-575
17. Hicklin DJ, Kageshita T, Ferrone S: Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing. Tissue Antigens 1996, 48:38-46
18. Stam NJ, Spits H, Ploegh HL: Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986, 137:2299-2306
19. Kageshita T, Nakamura M, Yamada, Kuriya N, Arao T, Ferrone S: Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. Cancer Res 1991, 51:1726-1732
20. Hicklin DJ, Kageshita T, Dellaratta D, Ferrone S: Transporter associated with antigen processing (TAP) downregulation in human melanoma cells. In HLA. Genetic Diversity of HLA. Functional and Medical Implication. Proceedings of the Twelfth International Histocompatibility Workshop and Conference. Vol. II. Edited by D Charron. Sevres, France, EDK, 1997, pp 742-744
21. White CA, Thomson SA, Cooper L, van Endert PM, Tampe R, Coupar B, Qiu L, Parsons PG, Moss DJ, Khanna R: Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells. Int J Cancer 1998, 75:590-595
22. Thor Straten P, Kirkin AF, Seremet T, Zeuthen J: Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines. Int J Cancer 1997, 70:582-586
23. Van Kaer L, Ashton Rickardt PG, Ploegh HL, Tonegawa S: TAP1 mutant mice are deficient in antigen presentation,surface class I molecules, and CD4-8+ T cells. Cell 1992, 71:1205-1214
24. Van Kaer L, Ashton Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S: Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994, 1:533-541
25. Fehling HJ, Swat W, Laplace C, Kuhn R, Rajewsky K, Muller U, von Boehmer H: MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994, 265:1234-1237
26. Cromme FV, van Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ: Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 1994, 69: 1176-1181
27. Cromme FV, Airey J, Heemels, M-T, Ploegh HL, Keating PJ, Stern PL, Meijer CJLM, Walboomers JMM: Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 1994, 179:335-340
28. Kaklamanis L, Townsend A, Doussis-Anagnostopoulou IA, Mortensen N, Harris AL, Gatter KC: Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 1994, 145:505-509
29. Kaklamanis L, Leek R, Koukourakis M, Gatter KC, Harris AL: Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res 1995, 55:5191-5194
30. Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC: Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 1996, 73:148-153
31. Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, Hicklin DJ, Ferrone S: HLA Class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res 1998, 58:737-742